U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807697) titled 'Quality of Life Before and After Radiotherapy in Patients With Head and Neck Cancer' on Jan. 29.
Brief Summary: Worldwide, head and neck cancers (HNCs) are widespread (650,000 cases per year) and cause more than 330,000 deaths per year. Almost all cases, about 90%, are cancers of the oral cavity, oropharynx, and larynx.
In conventional clinical practice, HNCs are treated primarily with radiation therapy (RT), often used in combination with surgery and/or chemotherapy. Like most anti-neoplastic therapies, RT carries significant adverse effects both acute and chronic. Both types of adverse effects have a significant impact on quality ...